Neucore Bio focuses on developing innovative biotechnologies aimed at addressing critical challenges in healthcare and agriculture. Their primary technology revolves around advanced synthetic biology, which enables the design and engineering of biological systems for various applications. This includes the creation of novel therapeutics and sustainable agricultural solutions that enhance crop resilience and productivity. By leveraging cutting-edge techniques in genetic engineering and metabolic pathway optimization, Neucore Bio aims to produce high-value bio-based products that can significantly improve health outcomes and environmental sustainability.

In addition to their synthetic biology initiatives, Neucore Bio emphasizes the importance of data-driven approaches in their research and development processes. They utilize sophisticated bioinformatics tools to analyze biological data, which aids in the identification of potential targets for drug development and the optimization of agricultural traits. This integration of computational biology with experimental techniques allows Neucore Bio to accelerate the discovery and commercialization of their products, ultimately contributing to advancements in biotechnology that can benefit both human health and food security.

United States

Neucore’s proprietary Fibroblast-Derived Engineering Extracellular Vesicles (FiXE™) platform enables unparalleled cell-targeted delivery of genetic therapeutics to address complex diseases and advance the next generation of functional skincare.

The FiXE platform harnesses the unique regenerative biology of fibroblasts—cells central to tissue repair and structural integrity—to engineer exosomes capable of restoring function at the cellular level, offering a cost effective, scalable solution for genetic medicine and dermatology.

Neucore Bio

Company Details